Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 118,718 | 102,803 | 84,780 | 109,383 | 131,416 |
| Cost of Goods | 53,048 | 55,277 | 44,227 | 46,601 | 50,938 |
| Gross Profit | 65,670 | 47,526 | 40,553 | 62,782 | 80,478 |
| Operating Expenses | 60,705 | 57,741 | 52,817 | 66,614 | 73,470 |
| Operating Income | 5,013 | -9,938 | -12,037 | -3,231 | 7,946 |
| Other Income | 1,326 | -947 | -757 | -1,494 | -670 |
| Pre-tax Income | 6,339 | -10,885 | -12,794 | -4,725 | 7,276 |
| Income Tax | 1,136 | -1,569 | -3,891 | -1,128 | 4,266 |
| Net Income Continuous | 5,203 | -9,316 | -8,903 | -3,597 | 3,010 |
| Net Income | $5,203 | $-9,316 | $-8,903 | $-3,597 | $3,010 |
| EPS Basic Total Ops | 0.16 | -0.28 | -0.26 | -0.11 | 0.09 |
| EPS Basic Continuous Ops | 0.15 | -0.28 | -0.26 | -0.11 | 0.09 |
| EPS Diluted Total Ops | 0.16 | -0.28 | -0.26 | -0.11 | 0.09 |
| EPS Diluted Continuous Ops | 0.15 | -0.28 | -0.26 | -0.11 | 0.09 |
| EPS Diluted Before Non-Recurring Items | 0.39 | 0.09 | N/A | N/A | N/A |
| EBITDA(a) | $12,139 | $-2,626 | $-5,354 | $3,763 | $15,722 |